An interventional study of FREMS in Chronic Ulcers, sponsored by Beni-Suef University. Completed at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Ulcer with a site in Egypt — 3 open to participants now, 3 under way, 1 of them phase 3. Ulcer · Egypt.
Among the 22 studies in Ulcer with a site in Egypt, this one is the 17th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2026, is one of 14 with no phase, and was the 22nd registered.
360 studies on the registry are indexed under Ulcer; 61 are open to participants now.
Browse Ulcer studies →3 of the 22 studies in Ulcer with a site in Egypt are open now. Recruiting first, the newest first:
British University In Egypt · Sites in Egypt
Mansoura University · Sites in Egypt
Ages 18–80 · Healthy volunteers
Cairo University · Sites in Egypt
Ages 40–60
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 39 Ulcer studies recruiting now, 30 (77%) set no upper age limit and 3 (8%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3 · Phase 4 1
First in 2012; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 26 is below the median of 65 across 292 interventional studies indexed under Ulcer.
Median enrollment 38 across the 20 interventional studies, 72 across the 2 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 22 have an industry lead sponsor. The 10 most frequent:
Beni-Suef University is the lead sponsor of 350 studies on the registry; 124 are open to participants now.
Beni-Suef University has 1 study filed under Ulcer — fewer than ten, so there is no comparison to draw.
2 of the studies in Ulcer with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06910579Phase 3British University In EgyptOxygenated Gel Therapy in the Management of Oral Aphthous Ulcers | 2027-01-30 |
| NCT07557524Cairo UniversityPulsed High Intensity Laser Versus Negative Pressure Therapy On Neuropathic Ulcers | 2027-02-28 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Ulcer with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of the study is to
Wound ulcers including diabetic foot ulcers impose a substantial and escalating economic burden on healthcare systems worldwide. In the United States alone, chronic wounds affect over 10 million people and account for annual healthcare costs ranging from $28.1 to $96.8 billion. Major challenges persist, including antibiotic resistance, high recurrence rates, delayed healing in patients with comorbidities, and limited evidence for many advanced therapies. Additionally, cost, access to specialized care, and the need for individualized, multidisciplinary management remain significant barriers to optimal outcomes. Using two effective modalities in cases that are resistant to all known treatments, whether they are conservative or adjuvant, is a promising technique to end the entrapment of a wound in a certain stage and avoid complications like further amputation. enrolled patients will be randomly assigned to one of either groups Group A: Intervention group that will receive 3 sessions /week of FERM with phenytoin application with spraying phenytoin topical 40 mg spray after each session according to ulcer size to cover the ulcer.
Group B: Control group that will receive standard of care and will be assessed at baseline and every month till they completed 3 months of treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
FREMS therapy 3 sessions/week for 40 minutes with phenytoin spray 40mg.
Device: FREMS
control group: SOC(debridement and basic wound care)
frequency rhythmic electrical stimulation which is an electrical device specialized in diabetes complications like ulcers and neuropathies, with proven efficacy in neuropathies, and promising results in ulcers.
healing rate
wound size
Time frame: measuring once a month for 3 months.
Plan to share: No
Ran from Jul 2026 to primary completion in Sep 2026, 2 months.
Of 44 non-industry interventional studies with no phase under Ulcer, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 64. This study's 2 months is below that.
Counting every sponsor, half of 69 studies reached it within 25 months; a quarter within 10 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.